Flatiron Health, a cancer software company based in New York City, will lay off 39 employees due to economic hardships Flatiron is experiencing.
The Latest
Chemo-brain, a commonly reported side effect of the cancer therapy, is not deeply understood, but new research is signaling that cognitive behavioral therapy and a combination of other methods could alleviate it, The Washington Post reported June 20.
Houston-based University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health are partnering to create an integrated cancer program in Louisiana.
U.S. News & World Report recently named its top children's hospital for pediatric cancer.
West Virginia University in Morgantown has received a $50 million investment from the state to expand its cancer research, according to a June 15 news release.
Columbus-based Ohio State University Comprehensive Cancer Center–The James researchers are preparing to launch a first-of-its-kind cancer clinical trial for a "smart drug" over telehealth.
Here are 107 oncologists starting new roles:
A survey found 93 percent and 70 percent of cancer centers are struggling with shortages of carboplatin and cisplatin, respectively, and while the FDA is trying to increase supply, hospitals are struggling to help patients.
A Cigna Healthcare study found administering pegfilgrastim, an injection used to prevent infection in cancer patients, in a home setting increased patient outcomes compared to administration in a nonhome setting.
The prognosis for women diagnosed with early-stage breast cancer has improved substantially since the 1990s, according to recent findings published in the BMJ.